Advent and Present-Day Status of Ligand Methods

  • Stephen H. Curry
Part of the Methodological Surveys in Biochemistry and Analysis book series (MSBA, volume 14)

Abstract

Biological methods have been crucial in pharmacological studies since the earliest days of quantitation. Disciplined use of bioassay allowed the discovery and quantitation of such endogenous compounds as acetylcholine and noradrenaline long before chemical assay became possible. In contrast, little was done in attempts to measure exogenous compounds introduced into the body until key developments in chemical analysis took place, notably with the Bratton-Mar shall reaction, absorption and fluorescence spectroscopy and, more recently, GC and HPLC. Specificity in chemical drug assays became a rigorous aim, often hinging on both work-up procedures and detection modes.

Keywords

Morphine Cocaine Methotrexate NADPH Charcoal 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Maggio, E.T., ed. (1980) Enzyme Immunoassay, CRC Press, Boca Raton, Florida, 295 pp.Google Scholar
  2. 2.
    Burgen, A.S.V. & Mitchell, J.F. (1978) Gaddum’s Pharmacology, 8th edn., Oxford Univ. Press, Oxford. - See pp. 229 – 247.Google Scholar
  3. 3.
    Alcid, D.V. & Seligman, S.J. (1973) Antimicrobial Agents & Chemotherapy 3, 559 – 561.Google Scholar
  4. 4.
    Berther, A. & Redfors, A. (1970) Clin. Pharmacol. Ther. 11, 665 – 673.Google Scholar
  5. 5.
    Berson, S.A. & Yalow, R.S. (1968) Clin. Chim. Acta 22, 51 – 69.CrossRefGoogle Scholar
  6. 6.
    Schall, R.F. & Teroso, H.J. (1981) Clin. Chem. 27, 1157 – 1164.Google Scholar
  7. 7.
    Wisdom, G.B. (1976) Clin. Chem. 22, 1243 – 1255.Google Scholar
  8. 8.
    Falk, L.C., Clard, D.R., Kalman, S.M. & Long, T.F. (1976) Clin. Chem. 22, 785 – 788.Google Scholar
  9. 9.
    Myers, C.E., Lippman, M.E., Eliot, H.M. & Chabner, B.A. (1975) Proc. Nat. Acad. Sci. 72, 3683 – 3686.CrossRefGoogle Scholar
  10. 10.
    Rubenstein, K.E., Schneider, R.S. & Ullman, E.F. (1972) Biochem. Biophys. Res. Comm. 47, 846 – 851.CrossRefGoogle Scholar
  11. 11.
    Burd, J.F., Wong, R.C., Feenery, J.E., Carrico, R.J. & Bogulaski, R.C. (1977) Clin. Chem. 23, 1402 – 1408.Google Scholar
  12. 12.
    Visor, G. & Schulman, S.G. (1981) J. Pharm. Sci. 70, 469 – 475.CrossRefGoogle Scholar
  13. 13.
    Curry, S.H. (1970) Br. J. Pharmacol. 39, 250 P.Google Scholar
  14. 14.
    Creese, I. & Snyder, S.H. (1977) Nature 270, 180 – 182.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Stephen H. Curry
    • 1
  1. 1.Division of Clinical Pharmacokinetics J. Hillis Miller Health CenterUniversity of FloridaGainesvilleUSA

Personalised recommendations